ID   SMG1_HUMAN              Reviewed;        3657 AA.
AC   Q96Q15; O43305; Q13284; Q8NFX2; Q96QV0; Q96RW3;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 2.
DT   02-NOV-2010, entry version 76.
DE   RecName: Full=Serine/threonine-protein kinase SMG1;
DE            Short=SMG-1;
DE            Short=hSMG-1;
DE            EC=2.7.11.1;
DE   AltName: Full=61E3.4;
DE   AltName: Full=Lambda/iota protein kinase C-interacting protein;
DE            Short=Lambda-interacting protein;
GN   Name=SMG1; Synonyms=ATX, KIAA0421, LIP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=9566925;
RA   Sanchez P., De Carcer G., Sandoval I.V., Moscat J., Diaz-Meco M.T.;
RT   "Localization of atypical protein kinase C isoforms into lysosome-
RT   targeted endosomes through interaction with p62.";
RL   Mol. Cell. Biol. 18:3069-3080(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, PHOSPHORYLATION OF
RP   RENT1, ALTERNATIVE SPLICING, ENZYME REGULATION, PHOSPHORYLATION,
RP   INTERACTION WITH RENT1; UPF2 AND UPF3, AND MUTAGENESIS OF ASP-2331.
RX   MEDLINE=21429078; PubMed=11544179; DOI=10.1101/gad.913001;
RA   Yamashita A., Ohnishi T., Kashima I., Taya Y., Ohno S.;
RT   "Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein
RT   kinase, associates with components of the mRNA surveillance complex
RT   and is involved in the regulation of nonsense-mediated mRNA decay.";
RL   Genes Dev. 15:2215-2228(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, PHOSPHORYLATION OF
RP   RENT1, COFACTOR, ENZYME REGULATION, AND MUTAGENESIS OF ASP-2331.
RX   MEDLINE=21303703; PubMed=11331269; DOI=10.1074/jbc.C100144200;
RA   Denning G., Jamieson L., Maquat L.E., Thompson E.A., Fields A.P.;
RT   "Cloning of a novel phosphatidylinositol kinase-related kinase:
RT   characterization of the human SMG-1 RNA surveillance protein.";
RL   J. Biol. Chem. 276:22709-22714(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, PHOSPHORYLATION OF
RP   TP53, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, ENZYME REGULATION,
RP   MUTAGENESIS OF ASP-2331, AND VARIANTS CYS-140 AND ILE-608.
RX   PubMed=15175154; DOI=10.1016/j.molcel.2004.05.005;
RA   Brumbaugh K.M., Otterness D.M., Geisen C., Oliveira V., Brognard J.,
RA   Li X., Lejeune F., Tibbetts R.S., Maquat L.E., Abraham R.T.;
RT   "The mRNA surveillance protein hSMG-1 functions in genotoxic stress
RT   response pathways in mammalian cells.";
RL   Mol. Cell 14:585-598(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1670-3657.
RC   TISSUE=Brain;
RX   MEDLINE=98116655; PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII.
RT   78 new cDNA clones from brain which code for large proteins in
RT   vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [6]
RP   SEQUENCE REVISION.
RX   MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2874-3657, TISSUE SPECIFICITY, AND
RP   INTERACTION WITH PRKCI.
RX   MEDLINE=96104559; PubMed=8524286;
RA   Diaz-Meco M.T., Municio M.M., Sanchez P., Lozano J., Moscat J.;
RT   "Lambda-interacting protein, a novel protein that specifically
RT   interacts with the zinc finger domain of the atypical protein kinase C
RT   isotype lambda/iota and stimulates its kinase activity in vitro and in
RT   vivo.";
RL   Mol. Cell. Biol. 16:105-114(1996).
RN   [8]
RP   DUPLICATION.
RX   PubMed=11948212; DOI=10.1093/jhered/92.6.462;
RA   Eichler E.E., Johnson M.E., Alkan C., Tuzun E., Sahinalp C.,
RA   Misceo D., Archidiacono N., Rocchi M.;
RT   "Divergent origins and concerted expansion of two segmental
RT   duplications on chromosome 16.";
RL   J. Hered. 92:462-468(2001).
RN   [9]
RP   INTERACTION WITH SMG5.
RX   MEDLINE=23001090; PubMed=14636577; DOI=10.1016/S1097-2765(03)00443-X;
RA   Ohnishi T., Yamashita A., Kashima I., Schell T., Anders K.R.,
RA   Grimson A., Hachiya T., Hentze M.W., Anderson P., Ohno S.;
RT   "Phosphorylation of hUPF1 induces formation of mRNA surveillance
RT   complexes containing hSMG-5 and hSMG-7.";
RL   Mol. Cell 12:1187-1200(2003).
RN   [10]
RP   INTERACTION WITH RENT1; UPF2; EST1A AND UPF3B.
RX   PubMed=12554878; DOI=10.1261/rna.2137903;
RA   Chiu S.-Y., Serin G., Ohara O., Maquat L.E.;
RT   "Characterization of human Smg5/7a: a protein with similarities to
RT   Caenorhabditis elegans SMG5 and SMG7 that functions in the
RT   dephosphorylation of Upf1.";
RL   RNA 9:77-87(2003).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3546 AND SER-3552, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3566 AND SER-3572, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3566; THR-3569; SER-3572
RP   AND THR-3573, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   CATALYTIC ACTIVITY, AND IDENTIFICATION IN THE SMG1C COMPLEX.
RX   PubMed=19417104; DOI=10.1101/gad.1767209;
RA   Yamashita A., Izumi N., Kashima I., Ohnishi T., Saari B.,
RA   Katsuhata Y., Muramatsu R., Morita T., Iwamatsu A., Hachiya T.,
RA   Kurata R., Hirano H., Anderson P., Ohno S.;
RT   "SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate
RT   remodeling of the mRNA surveillance complex during nonsense-mediated
RT   mRNA decay.";
RL   Genes Dev. 23:1091-1105(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-169, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   INTERACTION WITH TELO2 AND TTI1.
RX   PubMed=20427287; DOI=10.1074/jbc.M110.121699;
RA   Kaizuka T., Hara T., Oshiro N., Kikkawa U., Yonezawa K., Takehana K.,
RA   Iemura S., Natsume T., Mizushima N.;
RT   "Tti1 and Tel2 are critical factors in mammalian target of rapamycin
RT   complex assembly.";
RL   J. Biol. Chem. 285:20109-20116(2010).
RN   [18]
RP   INTERACTION WITH TTI1; RUVBL1; RUVBL2 AND POLR2E, AND IDENTIFICATION
RP   IN THE SMG1C COMPLEX.
RX   PubMed=20371770; DOI=10.1126/scisignal.2000468;
RA   Izumi N., Yamashita A., Iwamatsu A., Kurata R., Nakamura H., Saari B.,
RA   Hirano H., Anderson P., Ohno S.;
RT   "AAA+ proteins RUVBL1 and RUVBL2 coordinate PIKK activity and function
RT   in nonsense-mediated mRNA decay.";
RL   Sci. Signal. 3:RA27-RA27(2010).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-31; CYS-122; CYS-140; TYR-147;
RP   ASN-156; VAL-163; GLY-316; SER-461; ARG-542; SER-584; ILE-608;
RP   CYS-749; CYS-805; CYS-808; ILE-825; ASP-828; GLY-948; SER-965;
RP   LEU-1012; GLN-1025; SER-1068; HIS-1099; ARG-1271; PRO-1288; VAL-1328;
RP   PRO-1354; THR-1414; CYS-2167; SER-2254; LYS-2341; GLU-2726; SER-2885;
RP   ALA-2895; THR-3235 AND GLN-3579.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein kinase involved in both mRNA
CC       surveillance and genotoxic stress response pathways. Recognizes
CC       the substrate consensus sequence [ST]-Q. Plays a central role in
CC       nonsense-mediated decay (NMD) of mRNAs containing premature stop
CC       codons by phosphorylating UPF1/RENT1. Acts as part of the SMG1C
CC       complex, a mRNA surveillance complex that recognizes and degrades
CC       mRNAs containing premature translation termination codons (PTCs).
CC       The complex probably acts by associating with ribosomes during
CC       tranlation termination on mRNPs. If an exon junction complex (EJC)
CC       is located 50-55 or more nucleotides downstream from the
CC       termination codon, it phosphorylates UPF1/RENT1, triggering
CC       nonsense-mediated decay (NMD). Also acts as a genotoxic stress-
CC       activated protein kinase that displays some functional overlap
CC       with ATM. Can phosphorylate TP53/p53 and is required for optimal
CC       TP53/p53 activation after cellular exposure to genotoxic stress.
CC       Its depletion leads to spontaneous DNA damage and increased
CC       sensitivity to ionizing radiation (IR). May activate PRKCI but not
CC       PRKCZ.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Manganese.
CC   -!- ENZYME REGULATION: Inhibited by caffeine, LY294002 and wortmannin.
CC   -!- SUBUNIT: Component of a post-splicing multiprotein NMD complex
CC       with UPF1/RENT1, UPF2/RENT2, EST1A (SMG5/7a), EST1B/SMG5 and UPF3
CC       (UPF3A or UPF3B). Component of the SMG1C complex, at least
CC       composed of SMG1, SMG8 and SMG9. The SMG1C complex is then
CC       recruited on premature translation termination codons (PTCs) to
CC       form the ribosome:SURF complex, at least composed of ERF1, ERF3
CC       (ERF3A or ERF3B), EEF2, UPF1/RENT1, SMG1, SMG8 and SMG9. Interacts
CC       with PRKCI. Interacts with TELO2 and TTI1. Interacts with RUVBL1
CC       and RUVBL2. Interacts with POLR2E.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96Q15-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96Q15-2; Sequence=VSP_017748;
CC       Name=3;
CC         IsoId=Q96Q15-3; Sequence=VSP_017747;
CC       Name=4; Synonyms=BLIP;
CC         IsoId=Q96Q15-4; Sequence=VSP_017746;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest level in heart
CC       and skeletal muscle. Expressed in placenta, brain, lung and
CC       spleen, but not in liver.
CC   -!- PTM: Autophosphorylated (Probable). Phosphorylated upon DNA
CC       damage, probably by ATM or ATR.
CC   -!- MISCELLANEOUS: This gene is located in a region of chromosome 16
CC       that contains 2 segmental duplications. Other genes that are
CC       highly related to this exist, but they probably represent
CC       pseudogenes.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family.
CC   -!- SIMILARITY: Contains 1 FAT domain.
CC   -!- SIMILARITY: Contains 1 FATC domain.
CC   -!- SIMILARITY: Contains 1 HEAT repeat.
CC   -!- SIMILARITY: Contains 1 PI3K/PI4K domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA86535.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF186377; AAK58892.1; -; mRNA.
DR   EMBL; AB061371; BAB70696.1; -; mRNA.
DR   EMBL; AY014957; AAK00511.1; -; mRNA.
DR   EMBL; AF395444; AAM73708.1; -; mRNA.
DR   EMBL; AB007881; BAA24851.2; -; mRNA.
DR   EMBL; U32581; AAA86535.2; ALT_INIT; mRNA.
DR   IPI; IPI00183368; -.
DR   IPI; IPI00639874; -.
DR   IPI; IPI00640955; -.
DR   IPI; IPI00939320; -.
DR   PIR; JC6084; JC6084.
DR   RefSeq; NP_055907.3; -.
DR   UniGene; Hs.460179; -.
DR   ProteinModelPortal; Q96Q15; -.
DR   SMR; Q96Q15; 3626-3656.
DR   IntAct; Q96Q15; 8.
DR   MINT; MINT-1513197; -.
DR   STRING; Q96Q15; -.
DR   PhosphoSite; Q96Q15; -.
DR   PRIDE; Q96Q15; -.
DR   Ensembl; ENST00000446231; ENSP00000402515; ENSG00000157106.
DR   GeneID; 23049; -.
DR   KEGG; hsa:23049; -.
DR   UCSC; uc002dfm.1; human.
DR   CTD; 23049; -.
DR   GeneCards; GC16M018726; -.
DR   H-InvDB; HIX0038625; -.
DR   HGNC; HGNC:30045; SMG1.
DR   MIM; 607032; gene.
DR   HOVERGEN; HBG093965; -.
DR   InParanoid; Q96Q15; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 44092; -.
DR   ArrayExpress; Q96Q15; -.
DR   Bgee; Q96Q15; -.
DR   Genevestigator; Q96Q15; -.
DR   GermOnline; ENSG00000157106; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:UniProtKB.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process,...; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046854; P:phosphoinositide phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR015519; Ataxia_Telang_Mut.
DR   InterPro; IPR003152; FATC.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000403; PI3/4_kinase_cat.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR014009; PIK_FAT.
DR   Gene3D; G3DSA:1.25.10.10; ARM-like; 3.
DR   Gene3D; G3DSA:1.10.1070.11; PI3/4_kinase_cat; 3.
DR   PANTHER; PTHR11139:SF3; Ataxia_Telang_Mut; 1.
DR   Pfam; PF02260; FATC; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51189; FAT; 1.
DR   PROSITE; PS51190; FATC; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; FALSE_NEG.
DR   PROSITE; PS00915; PI3_4_KINASE_1; FALSE_NEG.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; DNA damage; DNA repair; Kinase; Manganese; Metal-binding;
KW   Nonsense-mediated mRNA decay; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1   3657       Serine/threonine-protein kinase SMG1.
FT                                /FTId=PRO_0000229791.
FT   DOMAIN     1127   1862       FAT.
FT   REPEAT     1813   1848       HEAT.
FT   DOMAIN     2146   2474       PI3K/PI4K.
FT   DOMAIN     3625   3657       FATC.
FT   MOD_RES     169    169       N6-acetyllysine.
FT   MOD_RES    3546   3546       Phosphothreonine.
FT   MOD_RES    3552   3552       Phosphoserine.
FT   MOD_RES    3566   3566       Phosphoserine.
FT   MOD_RES    3569   3569       Phosphothreonine.
FT   MOD_RES    3572   3572       Phosphoserine.
FT   MOD_RES    3573   3573       Phosphothreonine.
FT   VAR_SEQ       1   1265       Missing (in isoform 4).
FT                                /FTId=VSP_017746.
FT   VAR_SEQ       1    626       Missing (in isoform 3).
FT                                /FTId=VSP_017747.
FT   VAR_SEQ       1    136       Missing (in isoform 2).
FT                                /FTId=VSP_017748.
FT   VARIANT      31     31       A -> T.
FT                                /FTId=VAR_041623.
FT   VARIANT     122    122       R -> C.
FT                                /FTId=VAR_041624.
FT   VARIANT     140    140       S -> C.
FT                                /FTId=VAR_041625.
FT   VARIANT     147    147       N -> Y.
FT                                /FTId=VAR_041626.
FT   VARIANT     156    156       D -> N.
FT                                /FTId=VAR_041627.
FT   VARIANT     163    163       A -> V.
FT                                /FTId=VAR_041628.
FT   VARIANT     316    316       D -> G.
FT                                /FTId=VAR_041629.
FT   VARIANT     461    461       G -> S.
FT                                /FTId=VAR_041630.
FT   VARIANT     542    542       H -> R.
FT                                /FTId=VAR_041631.
FT   VARIANT     584    584       A -> S.
FT                                /FTId=VAR_041632.
FT   VARIANT     608    608       K -> I.
FT                                /FTId=VAR_041633.
FT   VARIANT     749    749       S -> C.
FT                                /FTId=VAR_041634.
FT   VARIANT     805    805       S -> C.
FT                                /FTId=VAR_041635.
FT   VARIANT     808    808       R -> C.
FT                                /FTId=VAR_041636.
FT   VARIANT     825    825       V -> I.
FT                                /FTId=VAR_041637.
FT   VARIANT     828    828       N -> D.
FT                                /FTId=VAR_041638.
FT   VARIANT     948    948       A -> G.
FT                                /FTId=VAR_041639.
FT   VARIANT     965    965       N -> S.
FT                                /FTId=VAR_041640.
FT   VARIANT    1012   1012       F -> L.
FT                                /FTId=VAR_041641.
FT   VARIANT    1025   1025       R -> Q.
FT                                /FTId=VAR_041642.
FT   VARIANT    1068   1068       T -> S.
FT                                /FTId=VAR_041643.
FT   VARIANT    1099   1099       N -> H.
FT                                /FTId=VAR_041644.
FT   VARIANT    1271   1271       P -> R.
FT                                /FTId=VAR_041645.
FT   VARIANT    1288   1288       Q -> P.
FT                                /FTId=VAR_041646.
FT   VARIANT    1328   1328       I -> V.
FT                                /FTId=VAR_041647.
FT   VARIANT    1354   1354       S -> P.
FT                                /FTId=VAR_041648.
FT   VARIANT    1414   1414       R -> T.
FT                                /FTId=VAR_041649.
FT   VARIANT    2167   2167       S -> C (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041650.
FT   VARIANT    2254   2254       G -> S.
FT                                /FTId=VAR_041651.
FT   VARIANT    2341   2341       M -> K.
FT                                /FTId=VAR_041652.
FT   VARIANT    2726   2726       Q -> E.
FT                                /FTId=VAR_041653.
FT   VARIANT    2885   2885       G -> S.
FT                                /FTId=VAR_041654.
FT   VARIANT    2895   2895       P -> A.
FT                                /FTId=VAR_041655.
FT   VARIANT    3235   3235       I -> T (in a breast infiltrating ductal
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041656.
FT   VARIANT    3579   3579       K -> Q (in a breast infiltrating ductal
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041657.
FT   MUTAGEN    2331   2331       D->A: Loss of function.
FT   CONFLICT    682    682       A -> S (in Ref. 3 and 4).
FT   CONFLICT    739    739       R -> K (in Ref. 3 and 4).
FT   CONFLICT   1189   1189       F -> C (in Ref. 3 and 4).
FT   CONFLICT   2005   2005       K -> R (in Ref. 2; BAB70696).
FT   CONFLICT   2073   2073       S -> N (in Ref. 1; AAK58892).
SQ   SEQUENCE   3657 AA;  410261 MW;  ADBBEA902F6B7DEA CRC64;
     MSRRAPGSRL SSGGTNYSRS WNDWQPRTDS ASADPGNLKY SSSRDRGGSS SYGLQPSNSA
     VVSRQRHDDT RVHADIQNDE KGGYSVNGGS GENTYGRKSL GQELRVNNVT SPEFTSVQHG
     SRALATKDMR KSQERSMSYS DESRLSNLLR RITREDDRDR RLATVKQLKE FIQQPENKLV
     LVKQLDNILA AVHDVLNESS KLLQELRQEG ACCLGLLCAS LSYEAEKIFK WIFSKFSSSA
     KDEVKLLYLC ATYKALETVG EKKAFSSVMQ LVMTSLQSIL ENVDTPELLC KCVKCILLVA
     RCYPHIFSTN FRDTVDILVG WHIDHTQKPS LTQQVSGWLQ SLEPFWVADL AFSTTLLGQF
     LEDMEAYAED LSHVASGESV DEDVPPPSVS LPKLAALLRV FSTVVRSIGE RFSPIRGPPI
     TEAYVTDVLY RVMRCVTAAN QVFFSEAVLT AANECVGVLL GSLDPSMTIH CDMVITYGLD
     QLENCQTCGT DYIISVLNLL TLIVEQINTK LPSSFVEKLF IPSSKLLFLR YHKEKEVVAV
     AHAVYQAVLS LKNIPVLETA YKLILGEMTC ALNNLLHSLQ LPEACSEIKH EAFKNHVFNV
     DNAKFVVKFD LSALTTIGNA KNSLIGMWAL SPTVFALLSK NLMIVHSDLA VHFPAIQYAV
     LYTLYSHCTR HDHFISSSLS SASPSLFDGA VISTVTTATK KHFSIILNLL GILLKKDNLN
     QDTRKLLMTW ALEAAVLMRK SETYAPLFSL PSFHKFCKGL LANTLVEDVN ICLQACSSLH
     ALSSSLPDDL LQRCVDVCRV QLVHSGTRIR QAFGKLLKSI PLDVVLSNNN HTEIQEISLA
     LRSHMSKAPS NTFHPQDFSD VISFILYGNS HRTGKDNWLE RLFYSCQRLD KRDQSTIPRN
     LLKTDAVLWQ WAIWEAAQFT VLSKLRTPLG RAQDTFQTIE GIIRSLAAHT LNPDQDVSQW
     TTADNDEGHG NNQLRLVLLL QYLENLEKLM YNAYEGCANA LTSPPKVIRT FFYTNRQTCQ
     DWLTRIRLSI MRVGLLAGQP AVTVRHGFDL LTEMKTTSLS QGNELEVTIM MVVEALCELH
     CPEAIQGIAV WSSSIVGKNL LWINSVAQQA EGRFEKASVE YQEHLCAMTG VDCCISSFDK
     SVLTLANAGR NSASPKHSLN GESRKTVLSK PTDSSPEVIN YLGNKACEFY ISIADWAAVQ
     EWQNAIHDLK KSTSSTSLNL KADFNYIKSL SSFESGKFVE CTEQLELLPG ENINLLAGGS
     KEKIDMKKLL PNMLSPDPRE LQKSIEVQLL RSSVCLATAL NPIEQDQKWQ SITENVVKYL
     KQTSRIAIGP LRLSTLTVSQ SLPVLSTLQL YCSSALENTV SNRLSTEDCL IPLFSEALRS
     CKQHDVRPWM QALRYTMYQN QLLEKIKEQT VPIRSHLMEL GLTAAKFARK RGNVSLATRL
     LAQCSEVQLG KTTTAQDLVQ HFKKLSTQGQ VDEKWGPELD IEKTKLLYTA GQSTHAMEML
     SSCAISFCKS VKAEYAVAKS ILTLAKWIQA EWKEISGQLK QVYRAQHQQN FTGLSTLSKN
     ILTLIELPSV NTMEEEYPRI ESESTVHIGV GEPDFILGQL YHLSSVQAPE VAKSWAALAS
     WAYRWGRKVV DNASQGEGVR LLPREKSEVQ NLLPDTITEE EKERIYGILG QAVCRPAGIQ
     DEDITLQITE SEDNEEDDMV DVIWRQLISS CPWLSELDES ATEGVIKVWR KVVDRIFSLY
     KLSCSAYFTF LKLNAGQIPL DEDDPRLHLS HRVEQSTDDM IVMATLRLLR LLVKHAGELR
     QYLEHGLETT PTAPWRGIIP QLFSRLNHPE VYVRQSICNL LCRVAQDSPH LILYPAIVGT
     ISLSSESQAS GNKFSTAIPT LLGNIQGEEL LVSECEGGSP PASQDSNKDE PKSGLNEDQA
     MMQDCYSKIV DKLSSANPTM VLQVQMLVAE LRRVTVLWDE LWLGVLLQQH MYVLRRIQQL
     EDEVKRVQNN NTLRKEEKIA IMREKHTALM KPIVFALEHV RSITAAPAET PHEKWFQDNY
     GDAIENALEK LKTPLNPAKP GSSWIPFKEI MLSLQQRAQK RASYILRLEE ISPWLAAMTN
     TEIALPGEVS ARDTVTIHSV GGTITILPTK TKPKKLLFLG SDGKSYPYLF KGLEDLHLDE
     RIMQFLSIVN TMFATINRQE TPRFHARHYS VTPLGTRSGL IQWVDGATPL FGLYKRWQQR
     EAALQAQKAQ DSYQTPQNPG IVPRPSELYY SKIGPALKTV GLSLDVSRRD WPLHVMKAVL
     EELMEATPPN LLAKELWSSC TTPDEWWRVT QSYARSTAVM SMVGYIIGLG DRHLDNVLID
     MTTGEVVHID YNVCFEKGKS LRVPEKVPFR MTQNIETALG VTGVEGVFRL SCEQVLHIMR
     RGRETLLTLL EAFVYDPLVD WTAGGEAGFA GAVYGGGGQQ AESKQSKREM EREITRSLFS
     SRVAEIKVNW FKNRDEMLVV LPKLDGSLDE YLSLQEQLTD VEKLQGKLLE EIEFLEGAEG
     VDHPSHTLQH RYSEHTQLQT QQRAVQEAIQ VKLNEFEQWI THYQAAFNNL EATQLASLLQ
     EISTQMDLGP PSYVPATAFL QNAGQAHLIS QCEQLEGEVG ALLQQRRSVL RGCLEQLHHY
     ATVALQYPKA IFQKHRIEQW KTWMEELICN TTVERCQELY RKYEMQYAPQ PPPTVCQFIT
     ATEMTLQRYA ADINSRLIRQ VERLKQEAVT VPVCEDQLKE IERCIKVFLH ENGEEGSLSL
     ASVIISALCT LTRRNLMMEG AASSAGEQLV DLTSRDGAWF LEELCSMSGN VTCLVQLLKQ
     CHLVPQDLDI PNPMEASETV HLANGVYTSL QELNSNFRQI IFPEALRCLM KGEYTLESML
     HELDGLIEQT TDGVPLQTLV ESLQAYLRNA AMGLEEETHA HYIDVARLLH AQYGELIQPR
     NGSVDETPKM SAGQMLLVAF DGMFAQVETA FSLLVEKLNK MEIPIAWRKI DIIREARSTQ
     VNFFDDDNHR QVLEEIFFLK RLQTIKEFFR LCGTFSKTLS GSSSLEDQNT VNGPVQIVNV
     KTLFRNSCFS EDQMAKPIKA FTADFVRQLL IGLPNQALGL TLCSFISALG VDIIAQVEAK
     DFGAESKVSV DDLCKKAVEH NIQIGKFSQL VMNRATVLAS SYDTAWKKHD LVRRLETSIS
     SCKTSLQRVQ LHIAMFQWQH EDLLINRPQA MSVTPPPRSA ILTSMKKKLH TLSQIETSIA
     TVQEKLAALE SSIEQRLKWA GGANPALAPV LQDFEATIAE RRNLVLKESQ RASQVTFLCS
     NIIHFESLRT RTAEALNLDA ALFELIKRCQ QMCSFASQFN SSVSELELRL LQRVDTGLEH
     PIGSSEWLLS AHKQLTQDMS TQRAIQTEKE QQIETVCETI QNLVDNIKTV LTGHNRQLGD
     VKHLLKAMAK DEEAALADGE DVPYENSVRQ FLGEYKSWQD NIQTVLFTLV QAMGQVRSQE
     HVEMLQEITP TLKELKTQSQ SIYNNLVSFA SPLVTDATNE CSSPTSSATY QPSFAAAVRS
     NTGQKTQPDV MSQNARKLIQ KNLATSADTP PSTVPGTGKS VACSPKKAVR DPKTGKAVQE
     RNSYAVSVWK RVKAKLEGRD VDPNRRMSVA EQVDYVIKEA TNLDNLAQLY EGWTAWV
//
